Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_notes_note in Note (approximate match)

Showing 6661 - 6670 of 6715 results

First page
Previous page
Next page
Next page

INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

HRT2X6KFJO

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

QWJHW3WEXS

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

WD5E5VYM2E

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1adcb911-4e6b-7b6f-e063-6394a90a8264

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1adcb911-4e6b-7b6f-e063-6394a90a8264

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

KJA387FHB2

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1adcb911-4e6b-7b6f-e063-6394a90a8264

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1adcb911-4e6b-7b6f-e063-6394a90a8264

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

IBB8KGB0WJ

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Y8O4RY7EEM

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

8KSK0802BP

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

KMO6TK08J4

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)

PRE3ERF7G4

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

A5WLI8WK8A

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Showing 6661 - 6670 of 6715 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1